427 results match your criteria: "Cleveland Clinic Lou Ruvo Center for Brain Health.[Affiliation]"

Neuropsychological test performance of former American football players.

Alzheimers Res Ther

January 2023

Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Robinson Building, Suite B7800, Boston, MA, 02118, USA.

Background: Patterns of cognitive impairment in former American football players are uncertain because objective neuropsychological data are lacking. This study characterized the neuropsychological test performance of former college and professional football players.

Methods: One hundred seventy male former football players (n=111 professional, n=59 college; 45-74 years) completed a neuropsychological test battery.

View Article and Find Full Text PDF

A growing body of literature shows the unequivocal importance of incorporating diversity-related factors into the practice of clinical neuropsychology. Thus, it is imperative that we continue to seek and obtain updated training and knowledge on how culture and diversity intersect with our clinical roles throughout our careers, not merely to satisfy initial coursework requirements. Although most professional organizations pertaining to clinical psychology - and thereby neuropsychology - strongly the pursuit of training in diversity-related factors, explicit for such training across one's career are minimal.

View Article and Find Full Text PDF

Deep brain stimulation (DBS) to the fornix is an investigational treatment for patients with mild Alzheimer's Disease. Outcomes from randomized clinical trials have shown that cognitive function improved in some patients but deteriorated in others. This could be explained by variance in electrode placement leading to differential engagement of neural circuits.

View Article and Find Full Text PDF

Objective: The radiologically isolated syndrome (RIS) represents the earliest detectable pre-clinical phase of multiple sclerosis (MS). This study evaluated the impact of therapeutic intervention in preventing first symptom manifestation at this stage in the disease spectrum.

Methods: We conducted a multi-center, randomized, double-blinded, placebo-controlled study involving people with RIS.

View Article and Find Full Text PDF

Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat Dementia.

J Exp Pharmacol

October 2022

Alzheimer's and Memory Disorders Division, Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.

Article Synopsis
  • Alzheimer’s disease (AD) is a common neurodegenerative condition primarily affecting individuals over 65, leading to significant cognitive decline due to increased neuron death compared to healthy brains.
  • Diagnosis of AD can only be confirmed after death through brain biopsies that detect amyloid beta (Aβ) plaques and tau tangles, which are believed to relate to the disease's progression.
  • Current treatments in clinical development focus on reducing Aβ levels, with passive immunotherapies like aducanumab and donanemab showing the most promise, potentially combined with other medications for better overall effectiveness.
View Article and Find Full Text PDF

Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summary.

Neurodegener Dis Manag

February 2023

Neurology Institute, Harley Street Medical Center, Abu Dhabi, UAE, & Nehme & Therese Tohme Multiple Sclerosis Center, American University of Beirut, Beirut, Lebanon.

What Is This Summary About?: People with multiple sclerosis (shortened to MS) who are taking cladribine tablets may have concerns about whether they can be vaccinated against COVID-19. This summary details the findings from a previously published article, in which an international committee of 10 MS experts developed recommendations to answer some important questions about COVID-19 vaccines in people with MS (including relapsing-remitting or active secondary progressive disease) taking cladribine tablets.

What Were The Results?: The committee identified 13 recommendations, which were all agreed upon by at least three-quarters (75%) of the 38 voting MS experts.

View Article and Find Full Text PDF

Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players.

Eur J Nucl Med Mol Imaging

January 2023

Boston University Alzheimer's Disease Research Center, Boston University CTE Center, Department of Neurology, Boston University School of Medicine, Boston, MA, USA.

Purpose: Flourine-18-flortaucipir tau positron emission tomography (PET) was developed for the detection for Alzheimer's disease. Human imaging studies have begun to investigate its use in chronic traumatic encephalopathy (CTE). Flortaucipir-PET to autopsy correlation studies in CTE are needed for diagnostic validation.

View Article and Find Full Text PDF

Effects of dose change on the success of clinical trials.

Contemp Clin Trials Commun

December 2022

Department of Neurology, University of Washington, Seattle, WA, 98195, United States of America.

The search for disease modifying therapies in Alzheimers disease (AD) has recently led to promising results but also revealed design issues in clinical trials themselves. Of particular importance is the potential statistical challenges that can arise when dosages change after an interim analysis, which is not uncommon in contemporary AD trials. Following the recent Aducanumab trials, we sought to study the implications of dose changes on the statistical power of an AD trial.

View Article and Find Full Text PDF

Introduction And Problem Statement: Neuroimmunology is a rapidly evolving subspecialty. At this time, fellowship training is not standardized. Discrepancies exist in fellowship programs across the United States, including in faculty expertise in rarer neuroimmunologic conditions.

View Article and Find Full Text PDF

Introduction: Evidence from in vitro and in vivo studies demonstrates that amyloid beta (Aβ) oligomers have potent, broad-spectrum antimicrobial properties created by fibrils that entrap pathogens and disrupt their membranes. Data suggest that Aβ may play a protective role in the innate immune response to microbial infections and that Aβ in the brain plays a damaging role when the inflammatory response is not well controlled.

Areas Covered: This paper describes the relationship between periodontal disease and Alzheimer disease (AD), the role of and its secreted gingipains in AD, and the potential of the gingipain inhibitor atuzaginstat (COR388) to modulate AD neuropathologies.

View Article and Find Full Text PDF

White matter hyperintensities in former American football players.

Alzheimers Dement

April 2023

Psychiatry Neuroimaging Laboratory, Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Introduction: The presentation, risk factors, and etiologies of white matter hyperintensities (WMH) in people exposed to repetitive head impacts are unknown. We examined the burden and distribution of WMH, and their association with years of play, age of first exposure, and clinical function in former American football players.

Methods: A total of 149 former football players and 53 asymptomatic unexposed participants (all men, 45-74 years) completed fluid-attenuated inversion recovery magnetic resonance imaging, neuropsychological testing, and self-report neuropsychiatric measures.

View Article and Find Full Text PDF

Measuring cognitive function is essential for characterizing brain health and tracking cognitive decline in Alzheimer's Disease and other neurodegenerative conditions. Current tools to accurately evaluate cognitive impairment typically rely on a battery of questionnaires administered during clinical visits which is essential for the acquisition of repeated measurements in longitudinal studies. Previous studies have shown that the remote data collection of passively monitored daily interaction with personal digital devices can measure motor signs in the early stages of synucleinopathies, as well as facilitate longitudinal patient assessment in the real-world scenario with high patient compliance.

View Article and Find Full Text PDF

Introduction: Late onset Alzheimer's disease (AD) is the most common form of dementia, in which almost 70% of patients are women.

Hypothesis: We hypothesized that women show worse global FC metrics compared to men, and further hypothesized a sex-specific positive correlation between FC metrics and cognitive scores in women.

Methods: We studied cognitively healthy individuals from the Alzheimer's Disease Neuroimaging Initiative cohort, with resting-state functional Magnetic Resonance Imaging.

View Article and Find Full Text PDF

Time exists in us, and our self exists in time. Our self is affected and shaped by time to the point that a better understanding of the former can aid the understanding of the latter. Psychoanalysis works through self and time, where the self is composed of the biopsychosocial history (the past) of the individual and able to map a trajectory for the future.

View Article and Find Full Text PDF

Introduction: Freezing of gait (FOG) is a highly disabling symptom in Parkinson's Disease (PD) with varying degree of benefits from oral dopaminergic medications and several subtypes that present with different medication states (e.g., off FOG, on FOG, pseudo-on FOG, supra-on FOG).

View Article and Find Full Text PDF

Siponimod is a selective sphingosine 1-phosphate receptor subtype 1 (S1P) and 5 (S1P) modulator approved in the United States and the European Union as an oral treatment for adults with relapsing forms of multiple sclerosis (RMS), including active secondary progressive multiple sclerosis (SPMS). Preclinical and clinical studies provide support for a dual mechanism of action of siponimod, targeting peripherally mediated inflammation and exerting direct central effects. As an S1P receptor modulator, siponimod reduces lymphocyte egress from lymph nodes, thus inhibiting their migration from the periphery to the central nervous system.

View Article and Find Full Text PDF
Article Synopsis
  • Lewy body dementia includes two main forms: dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), with no disease-modifying therapies currently available and limited FDA-approved treatments.
  • Cholinesterase inhibitors, like rivastigmine and donepezil, help improve cognitive symptoms, while levodopa can aid motor symptoms.
  • Research is ongoing, with trials focused on disease modification rather than just symptom relief; promising results from phase II trials, like neflamapimod, highlight the need for better biomarkers and outcome definitions in studies.
View Article and Find Full Text PDF

Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders.

Cell Rep Med

April 2022

Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL 32224, USA. Electronic address:

Article Synopsis
  • - The development of effective therapies for frontotemporal dementia (FTD) is hindered by a lack of reliable biomarkers for susceptibility, diagnosis, and prognosis.
  • - Blood neurofilament light (NfL) shows potential as a biomarker, with elevated levels found in all FTD syndromes and in individuals carrying FTD mutations before any symptoms appear.
  • - Measuring plasma NfL could help identify at-risk individuals for early diagnosis and treatment trials, ultimately improving patient care and trial outcomes.
View Article and Find Full Text PDF

Purpose: To assess the pathological aging effect on caudate functional connectivity among mild cognitive impairment (MCI) participants and examine whether and how sex and amyloid contribute to this process.

Materials And Methods: Two hundred and seventy-seven functional magnetic resonance imaging (fMRI) sessions from 163 cognitive normal (CN) older adults and 309 sessions from 139 participants with MCI were included as the main sample in our analysis. Pearson's correlation was used to characterize the functional connectivity (FC) between caudate nuclei and each brain region, then caudate nodal strength was computed to quantify the overall caudate FC strength.

View Article and Find Full Text PDF

Background: Decreased automaticity is common among individuals with neurodegenerative disease and is often assessed using dual-task (DT) paradigms. However, the best methods for assessing performance changes related to DT demands remain inconclusive.

Objective: To investigate the reliability and validity of a novel battery of DT measures (DT Effect-Battery (DTE-B)) encompassing three domains: task-specific interference, task prioritization, and automaticity.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated the relationship between tau PET biomarker [F]AV-1451 and episodic memory issues in adults with Down syndrome, building on the amyloid/tau/neurodegeneration (AT[N]) model.
  • - Researchers analyzed data from 123 non-demented adults with Down syndrome, using various memory tests and tau and amyloid beta PET assessments to gauge their cognitive performance.
  • - Results showed that high tau levels were linked to poorer episodic memory, particularly in participants with elevated amyloid beta, indicating that high tau could signal early signs of Alzheimer's disease in individuals with Down syndrome.
View Article and Find Full Text PDF

Purpose: As the COVID-19 pandemic resulted in social restrictions around the globe, this cross-sectional survey aimed to assess the impact of social isolation on self- or proxy-reported symptoms of Parkinson's disease (PD) during the pandemic.

Patients And Methods: The survey was distributed among 7109 subscribers of the Parkinson and Movement Disorders Alliance (PMD Alliance) News and Information list and was open only to people with PD (PwP) and care partners (CP, defined as main caregivers of PwP and serving as proxy respondents). No attempt was made to identify PwP and CP pairs.

View Article and Find Full Text PDF